Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired tarsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control

Journal of the American College of Cardiology

Volumn 30, Issue 6, 1997, Pages 1575-1584

  Verduyn, S Cora ^a   Vos, Marc A ^a   Van Der Zande, Jolanda ^a   Kulcsàr, Atilla ^a   Wellens, Hein J J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOKALANT; SOTALOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROSTIMULATION; EXTRASYSTOLE; FEMALE; HEART DEPOLARIZATION; HEART MUSCLE POTENTIAL; HEART PACING; HEART REPOLARIZATION; HEART STIMULATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; REPRODUCIBILITY; TORSADE DES POINTES;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOGS; ELECTROCARDIOGRAPHY; FEMALE; MALE; PROPANOLAMINES; REGRESSION ANALYSIS; SOTALOL; TORSADES DE POINTES;

EID: 0030657750     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00333-1     Document Type: Article

References (40)

1. Colatsky TJ, Follmer CH, Starmer CF. Channel specificity in antiarrhythmic drug action: mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 1990;82:2235-42.
2. Hondeghem LM, Snyders DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse use dependence. Circulation 1990;81:687-90.
3. Singh BN, Wellens HJJ, Hiraoka M, editors. Electropharmocological Control of Cardiac Arrhythmias: To Delay Conduction or to Prolong Refractoriness. Armonk (NY): Futura, 1994.
4. McNeil DJ, Davies RO, Deitchman D. Clinical safety profile in the treatment of arrhythmias. Am J Cardiol 1993;72:44A-50A.
5. Nguyen TP, Scheinman MM, Seger J. Polymorphous ventricular tachycardia: clinical characterization, therapy and QT interval. Circulation 1986;74: 340-9.
6. Hohnloser SH, Woosley RL. Sotalol. N Engl J Med 1994;331:31-8.
7. Hohnloser SH, Klingenleben T, Singh BN. Amiodarone-associated proarrhythmic effects: a review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994;121:529-35.
8. Wiesfeld ACP, Crijns HJGM, Bergstrand RH, Almgren O, Hillege HL, Lie KI. Torsade de pointes with almokalant, a new class III antiarrhythmic drug. Am Heart J 1993;126:1008-11.
9. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31:115-72.
10. Levine JH, Spear JF, Guarnieri T, et al. Cesium chloride-induced long QT syndrome: demonstration of afterdepolarizations and triggered activity in vivo. Circulation 1985;72:1092-103.
11. Carlsson L, Abrahamsson C, Andersson B, Düker G, Schiller-Linhardt G. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarizations. Cardiovasc Res 1993;27:2186-93.
12. Bonatti V, Rolli A, Botti G. Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes. Eur Heart J 1985;6 Suppl:131-43.
13. Bailie DS, Inoue H, Kaseda S, Ben David J, Zipes DP. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs. Circulation 1988;77:1395-402.
14. Surawicz B. Electrophysiological substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations. J Am Coll Cardiol 1989;14: 172-82.
15. Habbab MA, El-Sherif N. Drug induced torsade de pointes: role of early afterdepolarizations and dispersion of repolarization. Am J Med 1990;89: 241-6.
16. Vos MA, Verduyn SC, Gorgels APM, Lipscei GC, Wellens HJJ. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in the dog with chronic atrioventricular block. Circulation 1995;91:864-72.
17. Verduyn SC, Vos MA, van der Zande J, van der Hulst FF, Wellens HJ. Role of interventricular dispersion of repolarization in acquired torsade de pointes arrhythmias: reversal by magnesium. Cardiovasc Res 1997;34:453-63.
18. Vos MA, Gorgels APM, Lipscei GC, de Groot SHM, Leunissen JDM, Wellens HJJ. Mechanism specific anti-arrhythmic effects of the potassium channel activator levcromakalim against repolarization dependent tachycardias. J Cardiovasc Electrophysiol 1994;5:731-42.
19. Duker G, Almgren O, Carlsson L. Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)sotalol in the anesthetized dog. J Cardiovasc Pharmacol 1992;20:458-65.
20. Damiano BP, Rosen MR. Effects of pacing on triggered activity induced by early afterdepolarizations. Circulation 1984;69:1013-25.
21. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol 1994;23:259-77.
22. Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart evidence for the presence of M cells. J Am Coll Cardiol 1995;26:185-92.
23. Verduyn SC, Vos MA, Gorgels APM, Leunissen JDM, van der Zande J, Wellens HJJ. QT time: predictor of the occurrence of acquired torsade de pointes arrhythmias [abstract]. PACE 1994;17:826.
24. Hii JTY, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT time interval dispersion as a marker of torsade de pointes: disparate effects of class 1A antiarrhythmic drugs and amiodarone. Circulation 1992; 86:1376-82.
25. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995;25:746-52.
26. Statters DJ, Malik M, Ward DE, Camm AJ. QT dispersion: problems of methodology and clinical significance. J Cardiovasc Electrophysiol 1994;5: 672-85.
27. Nayebpour M, S Nattel. Pharmacologic response of cesium induced ventricular tachyarrhythmias in anesthetized dogs. J Cardiovasc Pharmacol 1990; 15:552-61.
28. Ben-David J, Zipes DP, Ayers GM, Pride HP. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of Bay K 8644. J Am Coll Cardiol 1992;20:1576-84.
29. Weissenburger J, Davy JM, Chezalviel F, et al. Arrhythmogenic activities of anti arrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. J Pharmacol Exp Ther 1991;259:871-83.
30. Carlsson L, Almgren O, Duker G. QTU prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions. J Cardiovasc Pharmacol 1990;16:276-85.
31. Buchanan LV, Kabell G, Brunden MN, Gibson JK. Comparative assessment of ibutilide, d-sotalol, clofilium, E4031, and UK-68,798 in a rabbit model of proarrhythmia. J Cardiovasc Pharmacol 1993;22:540-9.
32. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215.
33. Almgren O. Electropharmacological profile and antiarrhythmic potential of almokalant (H234/09). In: Singh BN, Wellens HJJ, Hiraoka M, editors. Electropharmocological Control of Cardiac Arrhythmias: To Delay Conduction or to Prolong Refractoriness. Armonk (NY), Futura, 1994:569-75.
34. Wettwer E, Grundke M, Ravens U. Differential effects of the new class III agents almokalant, E-4031 and d-sotalol and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes. Cardiovasc Res 1992; 26:1145-52.
35. Carmeliet E. Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther 1985;232:817-25.
36. Varro A, Nanasi PP, Lathrop DA. Effect of sotalol on transmembrane ionic currents responsible for repolarization in cardiac ventricular myocytes from rabbit and guinea pig. Life Sci 1991;49:PL7-9.
37. Nesterenko VV, Antzelevitch C. Factors responsible for "apparent" early afterdepolarizations (EADs) in monophasic actionpotential (MAP) recordings: a model study [abstract]. PACE 1995;18:830.
38. El-Sherif N, Restivo M, Caref EB, Piracha M. Electrophysiologic mechanism(s) of torsade de pointes ventricular tachyrrhythmias (TdP): tridimensional mapping of ventricular activation [abstract]. Circ Res 1995;92 Suppl I:I-641.
39. Kuo CS, Munakata K, Reddy P, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potentials. Circulation 1983;67:1356-67.
40. Abildskov JA, Lux RL. The mechanism of simulated torsade de pointes in a computer model of propagated excitation. J Cardiovasc Electrophysiol 1991;2:224-37.